OBI Pharma confirms FDA’s clearance of IND for Phase 1 Study of Monoclonal Antibody Cancer Immunotherapy Read more
MiMedx enrolls first patients in the Phase 3 IND Clinical Trial for treating Achilles Tendonitis Read more
APRINOIA Therapeutics finances US$11.1 Million Series B for developing imaging diagnostic and therapeutic pipelines Read more
FDA Commissioner Scott Gottlieb,M.D., vows to enhance clarity of Clinical Trial information Read more
Nils Hauptmann appointed Aerie Pharma’s Director of Regulatory Affairs and Pharmacovigilance Read more